Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2002 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: chloroquine phosphate

« Back to Dashboard

Summary for Generic Name: chloroquine phosphate

Drug Master File Entries: see list17
Therapeutic Class:Antiparasitics

Clinical Trials for: chloroquine phosphate

Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Status: Recruiting Condition: Carcinoma, Intraductal, Noninfiltrating; DCIS; Ductal Carcinoma In Situ

Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
Status: Recruiting Condition: Small Cell Lung Cancer

Chloroquine Population Pharmacokinetics in Pre and Post-partum Women
Status: Recruiting Condition: Vivax Malaria

Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer
Status: Recruiting Condition: Small Cell Lung Cancer

Status: Active, not recruiting Condition: Hepatitis, Autoimmune

A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects
Status: Completed Condition: Malaria Prophylaxis

Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors
Status: Recruiting Condition: Malignant Neoplasm; Solid Tumors

Chloroquine and Post Malaria Anaemia Study
Status: Completed Condition: Malaria Anaemia

Pharmacokinetic Study of Multi-dose Chloroquine
Status: Completed Condition: Malaria

Chloroquine Alone or in Combination for Malaria in Children in Malawi
Status: Completed Condition: Plasmodium Falciparum Infection

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Purepac Pharm
chloroquine phosphate
Tablet; Oral080886Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Impax Labs
chloroquine phosphate
Tablet; Oral080880Approved prior to Jan 1, 1982RXNo<disabled><disabled>
Md Pharm
chloroquine phosphate
Tablet; Oral087228Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Sanofi Synthelabo
chloroquine phosphate
Tablet; Oral006002Approved prior to Jan 1, 1982RXYes<disabled><disabled>
West Ward
chloroquine phosphate
Tablet; Oral083082SEP 17, 1999RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology